Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Inflammatory Bowel Diseases

  Free Subscription


03.09.2018

1 Aliment Pharmacol Ther
1 Am J Gastroenterol
2 Dig Dis Sci
1 Eur J Gastroenterol Hepatol
5 Inflamm Bowel Dis
1 J Crohns Colitis
1 Mediators Inflamm
1 PLoS One


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    Aliment Pharmacol Ther

  1. WEINBERG EM, Reddy KR
    Editorial: leave it unhooked? Possible benefits of ileostomy over ileal-pouch-anal anastomosis in patients with ulcerative colitis and primary sclerosing cholangitis in the setting of liver transplantation.
    Aliment Pharmacol Ther. 2018;48:581-582.
    PubMed     Text format    


    Am J Gastroenterol

  2. JAIRATH V
    Hyperbaric Oxygen for Hospitalized patients with Ulcerative Colitis.
    Am J Gastroenterol. 2018 Aug 29. pii: 10.1038/s41395-018-0224.
    PubMed     Text format     Abstract available


    Dig Dis Sci

  3. SHIN DS, Cheon JH, Park YE, Park Y, et al
    Extensive Disease Subtypes in Adult Patients with Ulcerative Colitis: Non-pancolitis Versus Pancolitis.
    Dig Dis Sci. 2018 Aug 25. pii: 10.1007/s10620-018-5218.
    PubMed     Text format     Abstract available

  4. FIORUCCI S, Biagioli M, Distrutti E
    Immunephenotype Predicts Response to Vedolizumab: Integrating Clinical and Biochemical Biomarkers in the Treatment of Inflammatory Bowel Diseases.
    Dig Dis Sci. 2018;63:2168-2171.
    PubMed     Text format    


    Eur J Gastroenterol Hepatol

  5. WALLDORF J, Twarz M, Schober C, Michl P, et al
    High frequency of secondary, but not primary ocular manifestations of inflammatory bowel disease in patients treated at a tertiary care center.
    Eur J Gastroenterol Hepatol. 2018 Aug 24. doi: 10.1097/MEG.0000000000001248.
    PubMed     Text format     Abstract available


    Inflamm Bowel Dis

  6. PEREZ-JELDRES T, Tyler CJ, Boyer JD, Karuppuchamy T, et al
    Cell Trafficking Interference in Inflammatory Bowel Disease: Therapeutic Interventions Based on Basic Pathogenesis Concepts.
    Inflamm Bowel Dis. 2018 Aug 24. pii: 5079145. doi: 10.1093.
    PubMed     Text format     Abstract available

  7. DE SILVA PS, O'Toole A, Marc LG, Ulysse CA, et al
    Development of a Sexual Dysfunction Scale for Women With Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2018 Jun 22. pii: 5042958. doi: 10.1093.
    PubMed     Text format     Abstract available

  8. AL-BAWARDY B, Ramos GP, Willrich MAV, Jenkins SM, et al
    Vedolizumab Drug Level Correlation With Clinical Remission, Biomarker Normalization, and Mucosal Healing in Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2018 Aug 24. pii: 5079133. doi: 10.1093.
    PubMed     Text format     Abstract available

  9. KAMAL A, Padival R, Lashner B
    Inflammatory Bowel Disease and Irritable Bowel Syndrome: What to Do When There Is an Overlap.
    Inflamm Bowel Dis. 2018 Aug 29. pii: 5086585. doi: 10.1093.
    PubMed     Text format    

  10. JACKSON BD, De Cruz P
    Quality of Care in Patients With Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2018 Aug 29. pii: 5086256. doi: 10.1093.
    PubMed     Text format     Abstract available


    J Crohns Colitis

  11. ARTOM M, Czuber-Dochan W, Sturt J, Norton C, et al
    Corrigendum: Targets for Health Interventions for Inflammatory Bowel Disease-fatigue.
    J Crohns Colitis. 2018 Aug 28. pii: 5085555. doi: 10.1093.
    PubMed     Text format    


    Mediators Inflamm

  12. TOLEDO-MAURINO JJ, Furuzawa-Carballeda J, Villeda-Ramirez MA, Fonseca-Camarillo G, et al
    The Transient Receptor Potential Vanilloid 1 Is Associated with Active Inflammation in Ulcerative Colitis.
    Mediators Inflamm. 2018;2018:6570371.
    PubMed     Text format     Abstract available


    PLoS One

  13. LE GALL G, Kirchgesner J, Bejaoui M, Landman C, et al
    Clinical activity is an independent risk factor of ischemic heart and cerebrovascular arterial disease in patients with inflammatory bowel disease.
    PLoS One. 2018;13:e0201991.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Inflammatory Bowel Diseases is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: